Presentation Information

[S14-5]Proposal of a novel therapeutic candidate for tuberous sclerosis based on the inhibitory effect of Rheb activation

Tadayuki Shimada1, Hiroko Sugiura1, Kanato Yamagata1,2 (1.Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2.Takada Nishishiro Hospital, Niigata, Japan)

Password required to view